Journal of Heterocyclic Chemistry · 2018 · 44 citations · 9 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologyStructure-activity RelationshipsAnalgesic PharmacologyLigand-based DesignNatural Product-based Drug DesignStructure-activity Relationship AnalysisAnalgesic Anti-inflammatory PharmacologyAnalgesic EffectsMedicinal Chemistry ApplicationsMolecular HybridsOrganic HybridsOxadiazole ChemistryQuinoxaline ChemistryQuinoxaline Synthesis
Novel hybrid molecules were synthesized through the amalgamation of quinoxaline residue with 1,3,4‐oxadiazole molecule. The purity of obtained 1,3,4‐oxadiazoles derivatives containing quinoxaline residue (total 11) was confirmed through thin‐layer chromatography, combustion analysis, and melting point, whereas their structures were confirmed by infrared spectroscopy, nuclear magnetic resonance, and mass spectroscopy. In animal studies, the derivatives 4‐(5‐(4‐(3‐methylquinoxalin‐2‐yl)phenyl)‐1,3,4‐oxadiazol‐2‐yl)benzenamine and 2‐(5‐(4‐(3‐methylquinoxalin‐2‐yl)phenyl)‐1,3,4‐oxadiazol‐2‐yl)benzenamine showed excellent analgesic and anti‐inflammatory activities, respectively, as compared with other derivatives. In order to rationalize the biological results of the derivatives, molecular docking studies were performed using Argus lab. The compounds exhibited good docking scores between −12.987 and −9.92 kcal/mol against cyclooxygenase‐II (5IKQ) protein fragment.
9
Panagiotis Zoumpoulakis, Ch. Camoutsis, George Pairas et al. · Bioorganic & Medicinal Chemistry · 2011 · 200 citations
Ebraheem Abdu Musad, Riyaz Mohamed, Bahjat A. Saeed et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 136 citations
Poonam Singh, Pramod Kumar Sharma, Jitendra Sharma et al. · Organic and Medicinal Chemistry Letters · 2012 · 50 citations · Full text